ABCL Stock: AbCellera Biologics Inc. Stock Price, Analysis & Insights
Get live abcl stock price $4.47, comprehensive AbCellera Biologics Inc. stock analysis, charts, news, and expert forecast. Real-time abcl stock data and investment insights.
Company Overview
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Company Information
- CEO
- Carl L.G. Hansen
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 596
Contact Information
- Website
- https://www.abcellera.com
- Address
- 2215 Yukon Street
- Country
- CA
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 1.34B market capitalization
- Trading Volume: 3.00M shares traded today
- Price Range: 52-week range of $1.89 - $5.82
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 1.34B, the company represents a significant player in its market. The stock is currently trading at $4.47 with a negativedaily change of 3.04%.
The company's 596 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -7.98, beta of 0.65, and 52-week price range from $1.89 to $5.82when evaluating investment opportunities.
Why Invest in AbCellera Biologics Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Carl L.G. Hansen
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.